1. The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel. Zijlstra A, Quigley JP (2006) Cancer Cell 10(3): 177-8
    › Primary publication · 16959609 (PubMed)
  2. Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Zijlstra A, Seandel M, Kupriyanova TA, Partridge JJ, Madsen MA, Hahn-Dantona EA, Quigley JP, Deryugina EI (2006) Blood 107(1): 317-27
    › Primary publication · 16174763 (PubMed) · PMC1895349 (PubMed Central)
  3. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Deryugina EI, Zijlstra A, Partridge JJ, Kupriyanova TA, Madsen MA, Papagiannakopoulos T, Quigley JP (2005) Cancer Res 65(23): 10959-69
    › Primary publication · 16322244 (PubMed)
  4. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Wilson S, Greer B, Hooper J, Zijlstra A, Walker B, Quigley J, Hawthorne S (2005) Biochem J 388(Pt 3): 967-72
    › Primary publication · 15537383 (PubMed) · PMC1183478 (PubMed Central)
  5. Genetic reprogramming of tumor cells by zinc finger transcription factors. Blancafort P, Chen EI, Gonzalez B, Bergquist S, Zijlstra A, Guthy D, Brachat A, Brakenhoff RH, Quigley JP, Erdmann D, Barbas CF (2005) Proc Natl Acad Sci U S A 102(33): 11716-21
    › Primary publication · 16081541 (PubMed) · PMC1187960 (PubMed Central)
  6. Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M, Deryugina EI, Quigley JP (2004) J Biol Chem 279(26): 27633-45
    › Primary publication · 15066996 (PubMed)
  7. Targeting the proteome/epitome, implementation of subtractive immunization. Zijlstra A, Testa JE, Quigley JP (2003) Biochem Biophys Res Commun 303(3): 733-44
    › Primary publication · 12670472 (PubMed)
  8. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D, Testa JE, Quigley JP (2003) Oncogene 22(12): 1783-94
    › Primary publication · 12660814 (PubMed)
  9. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Aimes RT, Zijlstra A, Hooper JD, Ogbourne SM, Sit ML, Fuchs S, Gotley DC, Quigley JP, Antalis TM (2003) Thromb Haemost 89(3): 561-72
    › Primary publication · 12624642 (PubMed)
  10. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Zijlstra A, Mellor R, Panzarella G, Aimes RT, Hooper JD, Marchenko ND, Quigley JP (2002) Cancer Res 62(23): 7083-92
    › Primary publication · 12460930 (PubMed)